BIOCON Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > biocon

Technical Analysis

Technical Strength: 7.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 62.3. According to RSI analysis, biocon is strong. 7.0 BIOCON RSI Chart
MACD (?) MACD: 18.9 and Signal Line: 16.1. According to MACD analysis, biocon is technically strong. 8.0 BIOCON MACD Chart
Simple Moving Average (?) According to simple moving average analysis, biocon is in a strong uptrend. Major support levels are 1103.402, 1069.605, 919.2202. 10.0 BIOCON Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, biocon is in a strong uptrend. Major support levels are 1108.17, 1069.167, 915.5591. 10.0 BIOCON Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.856. According to bollinger bands, biocon is technically strong. 7.0 BIOCON Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1100.7328 and 1084.85. Resistance level is 1152.15. 6.5 BIOCON Fibonacci Retracement Chart
Average True Range (?) ATR: 27.3 NA BIOCON Average True Range Chart
Average Directional Index (?) ADX is 19.3 which means BIOCON is in a trading range and there is no trend. NA BIOCON Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 24, 2017
Open Price 1126.1
High Price 1147.7
Low Price 1126.1
Close Price 1142.7
Absolute Change 14.1
Percentage Change 1.25%
Weekly Change 1.99%
Monthly Change 2.82%
Yearly Change 141%
52-week high 1152.15
52-week low 454.85
Corporate Actions
ExDate Purpose
June 22, 2016 ANNUAL GENERAL MEETING
March 17, 2016 INT DIV-RS 5 PER SHARE
March 17, 2016 INTERIM DIVIDEND
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.757
Confidence in Beta5.47%
Market Capital Rs. 22851.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 43.67
TTM Price-to-Earnings (P/E) Ratio 26.2
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 March 2017: Deliverable Quantity:1.32e+05 NA BIOCON Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 March 2017: Daily Volatility:0.3611 NA BIOCON Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 March 2017: PCR_OI:0.848 PCR:0.461 NA BIOCON PCR Chart
Premium (?) 24 March 2017 Premium: -1.5 Futures OI:2541000.0 NA BIOCON Premium Chart
Option_MAX_OI (?) 24 March 2017: Price:1142.7 Put with maximum OI:1060.0 Call with maximum OI:1160.0 NA BIOCON Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
March 30, 2017 1141.2 2541000.0 1737.0 1931.0 1142.7
April 27, 2017 1146.1 541800.0 241.0 351.0 1142.7
May 25, 2017 1154.15 92400.0 2.0 2.0 1142.7

Announcements

March 15, 2017 BiocAnalysts/Institutional Investor Meet/Con. Call Updatescon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
March 14, 2017 BiocUpdatescon Limited has informed the Exchange regarding Clarification in response to queries received from analysts/investors regarding Mylan s announcement related to its global settlement and license agreement with Genentech and Roche on Herceptin.
See all Announcements

Board Meetings

Date Meeting Date Purpose
December 27, 2016 January 24, 2017 InteResults/Otherser alia, consider, approve and take on record, the un-audited financial results (both standalone and consolidated) of the Company for the quarter ended December 31, 2016 amongst other routine matters.
October 07, 2016 October 20, 2016 inteResultser alia, to approve the un-audited financial results for the quarter and period ended on September 30, 2016.
See all Board Meetings

BIOCON is part of...

Index Weightage
NFTYMCAP50 NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1108 Rs. 1117 Rs. 1130 Rs. 1139 Rs. 1152 Rs. 1160 Rs. 1173